Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Roni Mamluk currently holds 265,345 shares of Ayala Pharmaceuticals, Inc. (AYLA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Roni Mamluk has been a net seller of AYLA stock. They have purchased $0 and sold $2.3M worth of shares.
Roni Mamluk's most recent insider trade was on Jan 19, 2023, when they sold 265,345 shares at $0.00 per share.
Roni Mamluk serves as Executive at Ayala Pharmaceuticals, Inc. (AYLA). They have executed 35 insider transactions totaling $2.3M over their tenure at the company.
Roni Mamluk holds the position of Executive at Ayala Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 9 years and currently hold a stake valued at $0.
Roni Mamluk has shown a selling trading pattern, with $0 in total purchases and $2.3M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Roni Mamluk was on Feb 20, 2020, when they sold $373.1K worth of CHMA shares. This transaction involved 82,186 shares at $4.54 per share.
Roni Mamluk currently owns 265,345 shares of Ayala Pharmaceuticals, Inc. (AYLA), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Roni Mamluk's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Roni Mamluk has 35 Form 4 filings on record as an insider at Ayala Pharmaceuticals, Inc..
Set alerts for Roni Mamluk and 40,000+ other insiders.